1. Home
  2. ENSC vs XPON Comparison

ENSC vs XPON Comparison

Compare ENSC & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.90

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Expion360 Inc.

XPON

Expion360 Inc.

HOLD

Current Price

$0.67

Market Cap

6.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENSC
XPON
Founded
2003
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.2M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
ENSC
XPON
Price
$0.90
$0.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
443.4K
235.3K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,487,973.00
$9,417,947.00
Revenue This Year
N/A
$61.26
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.51
109.37
52 Week Low
$0.86
$0.60
52 Week High
$9.57
$5.50

Technical Indicators

Market Signals
Indicator
ENSC
XPON
Relative Strength Index (RSI) 22.39 24.14
Support Level $0.86 $0.83
Resistance Level $1.24 $1.26
Average True Range (ATR) 0.10 0.08
MACD -0.01 -0.02
Stochastic Oscillator 7.72 2.06

Price Performance

Historical Comparison
ENSC
XPON

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About XPON Expion360 Inc.

Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.

Share on Social Networks: